Logo image of VMD

VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis

USA - NASDAQ:VMD - CA92663R1055 - Common Stock

6.26 USD
-0.17 (-2.64%)
Last: 11/6/2025, 8:20:55 PM
6.26 USD
0 (0%)
After Hours: 11/6/2025, 8:20:55 PM
Fundamental Rating

6

Taking everything into account, VMD scores 6 out of 10 in our fundamental rating. VMD was compared to 100 industry peers in the Health Care Providers & Services industry. VMD scores excellent on profitability, but there are some minor concerns on its financial health. VMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make VMD a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year VMD was profitable.
In the past year VMD had a positive cash flow from operations.
VMD had positive earnings in each of the past 5 years.
In the past 5 years VMD always reported a positive cash flow from operatings.
VMD Yearly Net Income VS EBIT VS OCF VS FCFVMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1.2 Ratios

VMD's Return On Assets of 7.57% is amongst the best of the industry. VMD outperforms 89.00% of its industry peers.
Looking at the Return On Equity, with a value of 10.00%, VMD is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
VMD has a better Return On Invested Capital (7.91%) than 73.00% of its industry peers.
VMD had an Average Return On Invested Capital over the past 3 years of 7.66%. This is in line with the industry average of 9.42%.
The 3 year average ROIC (7.66%) for VMD is below the current ROIC(7.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.57%
ROE 10%
ROIC 7.91%
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
VMD Yearly ROA, ROE, ROICVMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

VMD has a better Profit Margin (5.80%) than 81.00% of its industry peers.
VMD's Profit Margin has declined in the last couple of years.
VMD has a better Operating Margin (6.82%) than 68.00% of its industry peers.
VMD's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 58.33%, VMD is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
VMD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.82%
PM (TTM) 5.8%
GM 58.33%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
VMD Yearly Profit, Operating, Gross MarginsVMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

VMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VMD has more shares outstanding than it did 1 year ago.
VMD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VMD has been reduced compared to a year ago.
VMD Yearly Shares OutstandingVMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
VMD Yearly Total Debt VS Total AssetsVMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

VMD has an Altman-Z score of 5.76. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.76, VMD belongs to the top of the industry, outperforming 86.00% of the companies in the same industry.
VMD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, VMD belongs to the top of the industry, outperforming 82.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 5.76
ROIC/WACC0.85
WACC9.33%
VMD Yearly LT Debt VS Equity VS FCFVMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

VMD has a Current Ratio of 1.48. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of VMD (1.48) is comparable to the rest of the industry.
A Quick Ratio of 1.37 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a Quick ratio of 1.37. This is comparable to the rest of the industry: VMD outperforms 52.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.37
VMD Yearly Current Assets VS Current LiabilitesVMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.22% over the past year.
The Earnings Per Share has been growing slightly by 4.01% on average over the past years.
VMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.54%.
VMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.80% yearly.
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
Revenue 1Y (TTM)22.54%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.97%

3.2 Future

The Earnings Per Share is expected to grow by 24.89% on average over the next years. This is a very strong growth
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.73% yearly.
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VMD Yearly Revenue VS EstimatesVMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
VMD Yearly EPS VS EstimatesVMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

6

4. Valuation

4.1 Price/Earnings Ratio

VMD is valuated rather expensively with a Price/Earnings ratio of 18.97.
Based on the Price/Earnings ratio, VMD is valued a bit cheaper than 70.00% of the companies in the same industry.
VMD is valuated rather cheaply when we compare the Price/Earnings ratio to 25.67, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.78, VMD is valued correctly.
Based on the Price/Forward Earnings ratio, VMD is valued a bit cheaper than 79.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (31.86), we can say VMD is valued rather cheaply.
Industry RankSector Rank
PE 18.97
Fwd PE 12.78
VMD Price Earnings VS Forward Price EarningsVMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VMD is valued cheaper than 91.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.47
VMD Per share dataVMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)0.61
PEG (5Y)4.73
EPS Next 2Y32.27%
EPS Next 3Y24.89%

0

5. Dividend

5.1 Amount

No dividends for VMD!.
Industry RankSector Rank
Dividend Yield N/A

VIEMED HEALTHCARE INC

NASDAQ:VMD (11/6/2025, 8:20:55 PM)

After market: 6.26 0 (0%)

6.26

-0.17 (-2.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners68.04%
Inst Owner ChangeN/A
Ins Owners13.25%
Ins Owner Change1%
Market Cap242.83M
Revenue(TTM)224.26M
Net Income(TTM)13.98M
Analysts80
Price Target13.94 (122.68%)
Short Float %1.14%
Short Ratio2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)6.08%
Min EPS beat(4)-5.7%
Max EPS beat(4)32.01%
EPS beat(8)1
Avg EPS beat(8)-11.48%
EPS beat(12)3
Avg EPS beat(12)-7.67%
EPS beat(16)4
Avg EPS beat(16)-7.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.49%
Revenue beat(8)5
Avg Revenue beat(8)-0.39%
Revenue beat(12)8
Avg Revenue beat(12)0.05%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)0%
PT rev (3m)5.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.59%
Valuation
Industry RankSector Rank
PE 18.97
Fwd PE 12.78
P/S 1.01
P/FCF N/A
P/OCF 5.67
P/B 1.74
P/tB 2.29
EV/EBITDA 5.47
EPS(TTM)0.33
EY5.27%
EPS(NY)0.49
Fwd EY7.83%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.1
OCFY17.64%
SpS6.21
BVpS3.6
TBVpS2.73
PEG (NY)0.61
PEG (5Y)4.73
Graham Number5.17
Profitability
Industry RankSector Rank
ROA 7.57%
ROE 10%
ROCE 11.16%
ROIC 7.91%
ROICexc 9.15%
ROICexgc 12.45%
OM 6.82%
PM (TTM) 5.8%
GM 58.33%
FCFM N/A
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexgc growth 3Y2.65%
ROICexgc growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 0.08
Cap/Depr 176.74%
Cap/Sales 19.28%
Interest Coverage 25.41
Cash Conversion 100.29%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.37
Altman-Z 5.76
F-Score8
WACC9.33%
ROIC/WACC0.85
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)22.54%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.97%
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y5.79%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year219.91%
EBIT Next 3Y63.61%
EBIT Next 5YN/A
FCF growth 1Y-132.43%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y26.82%
OCF growth 3Y20.23%
OCF growth 5Y15.41%

VIEMED HEALTHCARE INC / VMD FAQ

What is the ChartMill fundamental rating of VIEMED HEALTHCARE INC (VMD) stock?

ChartMill assigns a fundamental rating of 6 / 10 to VMD.


What is the valuation status for VMD stock?

ChartMill assigns a valuation rating of 6 / 10 to VIEMED HEALTHCARE INC (VMD). This can be considered as Fairly Valued.


Can you provide the profitability details for VIEMED HEALTHCARE INC?

VIEMED HEALTHCARE INC (VMD) has a profitability rating of 7 / 10.


What is the earnings growth outlook for VIEMED HEALTHCARE INC?

The Earnings per Share (EPS) of VIEMED HEALTHCARE INC (VMD) is expected to grow by 31.06% in the next year.